Ancistrocladus abbreviatus
Ancistrocladus abbreviatus · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Ancistrocladus abbreviatus is a botanical species that has garnered significant interest within pharmacological research. Recent scientific investigations have focused on the specific medicinal potential of its root components. Researchers have utilized specialized preparations, such as CH2Cl2/NH3 root extracts, to study its chemical properties. These studies primarily aim to evaluate the plant's effectiveness as potent antiviral agents. Consequently, this species represents a promising subject in the ongoing search for new antiviral activities.
- Synonyms
- Not available
- Common names
- Not available
- Family
- Ancistrocladaceae
- Distribution
- Not available
- Plant Parts
- Root
Classification
Taxonomy
Ancistrocladus abbreviatus is a distinct member of the kingdom Plantae. Within this vast biological realm, the species is classified under the class Equisetopsida. It belongs to the order Caryophyllales, showcasing its specific evolutionary placement. Furthermore, the plant is nested within the family Ancistrocladaceae. Ultimately, these taxonomic layers define its identity under the genus Ancistrocladus.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Caryophyllales |
| Family | Ancistrocladaceae |
| Genus | Ancistrocladus |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Ancistrocladus abbreviatus is a distinctive plant species primarily found within the lush landscapes of West Tropical Africa. Its natural range extends across several key nations, including Ghana and Guinea, where it thrives in specific ecological niches. The species is also well-documented throughout the Ivory Coast and Liberia, highlighting its importance to the regional flora. Furthermore, its distribution continues into Nigeria, marking a significant presence within the West African tropical belt. Understanding these geographic patterns provides vital insight into the environmental requirements of this unique plant.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Ancistrocladus abbreviatus is characterized by an obligatory climbing habit, meaning it relies entirely on other structures for physical support to reach light.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Ancistrocladus abbreviatus serves as a compelling example of how ethnobotanical research can lead to significant medical breakthroughs. By exploring traditional African medicinal plants, scientists have successfully identified various biologically active molecules for modern use. Notably, this specific species has been recognized for its potent antiviral properties. Such discoveries highlight the importance of the classical approach to drug development through the identification of single plant species. Ultimately, these findings underscore the immense potential held within the natural environment to provide new therapeutic agents.
Compounds
Conditions
Ancistrocladus abbreviatus contains various alkaloids that demonstrate significant antiplasmodial activities. Specifically, the plant has been shown to treat Plasmodium berghei (Anka strain) through the use of its naphthylisoquinoline constituents. The species also produces compounds that exhibit potent cytotoxic activities, such as jozimine A2 which targets human cancer cells. This cytotoxicity against fibrosarcoma (HT1080) is one of several documented medicinal properties of the plant's chemical profile. Additionally, the plant is recognized for providing recently identified antiviral agents.
Preparations
Ancistrocladus abbreviatus is prepared as extracts to test their biological properties against malaria parasites. Specifically, this plant is prepared as a CH2Cl2/NH3 root extract to evaluate its efficacy. These specialized extracts are utilized to study the inhibition of the exoerythrocytic stages of Plasmodium berghei. The research highlights how these prepared forms of Ancistrocladus abbreviatus demonstrate significant in vitro activity. Through these specific preparation methods, the plant's medicinal potential against parasitic development is assessed.
Parts used
Ancistrocladus abbreviatus is a tropical plant species known for its significant pharmacological potential. Research indicates that extracts derived from the root of this plant contain potent naphthylisoquinoline alkaloids. These specific compounds have demonstrated a remarkable ability to retard the development of the rodent malaria parasite, Plasmodium berghei, within human hepatoma cells. In laboratory tests, the root extract achieved growth inhibition levels that were comparable to the effects of the commercial drug primaquine diphosphate. Such findings highlight the medicinal importance of utilizing different plant parts, like the root, to discover new antimalarial treatments.